BackClover Health Investments Overview
Clover Health Investments Corp - Ordinary Shares - Class A

Clover Health Investments Target Price

See Clover Health Investments's analyst price targets ($5.5) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$4.48

Average Target Price

$5.5022.8% upside

3 analysts in the last 4 months

High: $6 | Low: $5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-10Deutsche Bank$633.9% upsideOpen
2026-08-06UBSJonathan Yong$511.6% upsideOpen
2026-07-21Canaccord Genuity$5.522.8% upsideOpen
2026-06-11UBSJonathan Yong$4.756% upsideOpen
2026-06-04Canaccord GenuityRichard Close$4.26.3% downsideOpen
2025-10-21Leerink PartnersWhit Mayo$333% downsideOpen
2024-12-17Craig-HallumMatt Hewitt$633.9% upsideOpen
2024-08-06Canaccord GenuityRichard Close$2.544.2% downsideOpen
2022-11-16Citigroup$1.859.8% downsideOpen

Clover Health Investments (CLOV) FAQ

As of the most recent data, CLOV shows a target price of $5.5. Scroll down for historical charts and peer comparison views.

If Clover Health Investments moved to the average analyst target of $5.5, shares would be roughly 22.8% higher than $4.48. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Clover Health Investments's earnings trajectory.

Besides this target price page, Stockcircle has Clover Health Investments's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $5.5) with ownership activity and broader fundamentals.

Clover Health Investments's target price is $5.5; compare it with other Finance names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.